IMMUNOVANT, INC. (IMVT)

SEC filing

IMMUNOVANT, INC.

IMVT · CIK 1764013

4 · Oct 5, 2026 · Director, Chief Executive Officer Venker Eric sold 3,506 shares at $34.11/share ($119.6K); exercised options for 184.37K shares; reported 85.89K shares

Director, Chief Executive Officer Venker Eric sold 3,506 shares at $34.11/share ($119.6K); exercised options for 184.37K shares; reported 85.89K shares

Filed: Oct 5, 2026
Accession: 0001764013-26-000110
Filer: Immunovant, Inc.

View on SEC.gov All SEC filings

Could not load the primary document from EDGAR (SEC rate limit, timeout, or temporary upstream error). Refresh in a minute, or use View on SEC.gov.